Animal Molecular Breeding, 2024, Vol.14, No.6, 345-353 http://animalscipublisher.com/index.php/amb 350 6.3 Analysis of results and implications for future breeding The results of this study demonstrated that precise CRISPR/Cas9 gene editing could confer resistance to ALV-J in chickens without any visible side effects. This finding is significant as it highlights the potential of CRISPR/Cas9 technology to enhance disease resistance in poultry, thereby reducing economic losses and improving animal welfare (Islam et al., 2020; Gul et al., 2022). The successful implementation of CRISPR/Cas9 in this case study opens up new possibilities for breeding disease-resistant poultry. By targeting specific genes associated with disease susceptibility, it is possible to develop chicken strains that are resilient to various pathogens. This approach could significantly decrease the reliance on antibiotics and vaccines, promoting more sustainable and health-conscious poultry farming practices (Vilela et al., 2020). 7 Future Directions in Gene Editing for Poultry Breeding 7.1 Innovations in gene editing tools and techniques The CRISPR/Cas9 system has revolutionized gene editing in poultry, allowing for precise modifications in the avian genome. Recent advancements have focused on improving the efficiency and specificity of these tools. For instance, CRISPR technology has been successfully applied to modify genes in chickens and quails, enhancing genetic variations that are beneficial for poultry production. However, there is still room for improvement in the techniques used to achieve heritable edited traits in birds, which are currently quite involved and specific to avian reproductive biology (Tizard et al., 2019). Future innovations may include more refined methods for germline editing and the development of new gene-editing tools that can overcome the current limitations of CRISPR/Cas9 (Preethi et al., 2020). 7.2 Potential for integrating multi-omics approaches The integration of multi-omics approaches, including genomics, transcriptomics, proteomics, and metabolomics, holds significant potential for advancing poultry breeding. These technologies can provide comprehensive insights into the genetic and molecular basis of important traits such as disease resistance, productivity, and welfare (Dehau et al., 2022). The decreasing cost of omics technologies makes their implementation in routine poultry monitoring systems more feasible, potentially leading to the development of diagnostic tests based on disease-specific biomarkers (Goossens et al., 2022). By combining multi-omics data with gene editing, researchers can achieve a more precise and holistic understanding of complex traits, thereby enhancing the effectiveness of breeding programs (Langridge and Fleury, 2011; Mahmood et al., 2022). 7.3 Prospects for commercialization and industry adoption The commercialization and industry adoption of gene editing technologies in poultry breeding face several challenges, including regulatory hurdles and public perception. The regulatory landscape for genome-edited animals varies significantly across countries, which could lead to disparities in the adoption of these technologies and potential trade disruptions (Bishop and Eenennaam, 2020). Despite these challenges, the potential benefits of gene editing, such as improved disease resistance and enhanced productivity, make it an attractive option for the poultry industry. The successful commercialization of gene-edited poultry will likely depend on achieving regulatory harmony and addressing public concerns about the safety and ethics of these technologies. As the technology matures and becomes more widely accepted, it is expected that gene editing will play a crucial role in the future of poultry breeding (Khwatenge and Nahashon, 2021). 8 Concluding Remarks The application of CRISPR/Cas9 technology in poultry breeding has shown significant promise and progress. CRISPR/Cas9 has been successfully utilized to modify gene functions for various purposes, including transcriptional regulation, gene targeting, and epigenetic modification in poultry species, particularly chickens and quails. This technology has enabled the precise editing of viral genomes, aiding in the development of novel poultry vaccines and enhancing resistance to avian diseases. Additionally, CRISPR/Cas9 has been employed to achieve targeted mutagenesis and homologous recombination in chicken cell lines, demonstrating high efficiency
RkJQdWJsaXNoZXIy MjQ4ODYzNA==